The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

Case Report on Complete Response and 5 year Survival of Non-Small Cell Lung Cancer IIIB Patient Treated with Integrative Medicine

한양방통합치료로 완치되어 5년 생존에 도달한 3기B 비소세포성폐암 증례 보고

  • Bang, Sunhwi (Hwirim Korean Medicine Hospital) ;
  • Yun, Youngju (School of Korean Medicine, Pusan National University) ;
  • Choi, Junyong (School of Korean Medicine, Pusan National University) ;
  • Han, Changwoo (School of Korean Medicine, Pusan National University) ;
  • Kim, Soyeon (School of Korean Medicine, Pusan National University) ;
  • Park, Seongha (School of Korean Medicine, Pusan National University) ;
  • Hong, Jinwoo (School of Korean Medicine, Pusan National University) ;
  • Kwon, Jungnam (School of Korean Medicine, Pusan National University) ;
  • Lee, In (School of Korean Medicine, Pusan National University)
  • 방선휘 (휘림한방병원) ;
  • 윤영주 (부산대학교 한의학전문대학원) ;
  • 최준용 (부산대학교 한의학전문대학원) ;
  • 한창우 (부산대학교 한의학전문대학원) ;
  • 김소연 (부산대학교 한의학전문대학원) ;
  • 박성하 (부산대학교 한의학전문대학원) ;
  • 홍진우 (부산대학교 한의학전문대학원) ;
  • 권정남 (부산대학교 한의학전문대학원) ;
  • 이인 (부산대학교 한의학전문대학원)
  • Received : 2021.01.18
  • Accepted : 2021.02.15
  • Published : 2021.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This is a five-year survival case report on non-small cell lung cancer (NSCLC) treated with western medicine and traditional Korean medicine. 44-year old man diagnosed NSCLC IIIB in 2015 went through two months' concurrent chemoradiotherapy (CCRT) first, however the cancer did not response. After CCRT he began to take intensive integrative therapy including acupuncture, abdominal moxibustion, wild ginseng pharmacopuncture, herbal medicinal product of ginseng, hyperthermia, Thymosin α1, and mega vitamin C injection for 4 years and 9 months. After three months of intensive treatment, the state of cancer changed first to partial response and then complete response. He finally succeeded in five-year survival without any recurrence or complication in 2020, We suggest that integrative approach including traditional Korean medicine can be a meaningful treatment option for nonoperable NSCLC. Further studies with more cases should be performed to establish proper treatment protocol of integrative medicine for lung cancer.

비소세포성폐암 3기B 진단을 받고, 표준치료인 동시항암방사선치료를 시행했으나 별무효과였던 40대 남자에게, 한양방통합치료를 장기간 집중적으로 시행한 결과, 3개월만에 완전 관해에 도달하고, 5년 생존에 성공함으로써 한양방통합치료의 가능성을 보여 주었기에, 이에 증례를 보고한다.

Keywords

Acknowledgement

이 과제는 부산대학교 기본연구 지원사업(2년)에 의하여 연구되었음.

References

  1. Annual Report of national cancer statistics in Korea in 2017. National Cancer Center. 2019.
  2. Jeong SH, Jung JH, Lee HW, Kang SY, choi YW, Ahn MS, et al. Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer. J Lung Cancer. 2009;8(1);8-12. https://doi.org/10.6058/jlc.2009.8.1.8
  3. Wu X, Chung VC, Lu P, Poon SK, Hui EP, Lau AY, et al. Chinese Herbal Medicine for Improving Quality of Life Among Nonsmall Cell Lung Cancer Patients: Overvies of Systematic Reviews and Network Meta-Analysis. Medicine. 2016;95(1):e2410. https://doi.org/10.1097/md.0000000000002410
  4. Liu J, Lin HS, Hou W, Hua BJ, Zhang PT, Li J, et al. Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort study. Chin J Integr Med. 2017;23(10):733-739. https://doi.org/10.1007/s11655-016-2737-1
  5. Han GJ, Cho MJ, Park EJ, Seong S, Kim SS, Kim KI, et al. Analysis of existing guidelines and randomized, controlled, clinical trials for development of [guideline of clinical trial with herbal medicinal product for lung cancer]. J Korean Med. 2019;40(1):153-173. https://doi.org/10.13048/jkm.19012
  6. Jung HJ, Kim JD. The Role of Korean Medicine for Treatment and Management for Lung Cancer. J Kor Trad Oncol. 2015;20(1):45-54. https://doi.org/10.15432/JKTO.2015.20.1.045
  7. Kin KS. Case Study: Regression of a residual tumor and prolongation of overall survival with allergen-removed Rhus Verniciflua stokes after chemoradiotherapy in locally advanced non-small cell lung cancer. J Int Korean Med.2015;36(2):200-206.
  8. Park SJ, Kang HJ, Park JH, Cho CK, Yoo HS. A case report of a clinically diagnosed advanced lung cancer patient after treatment with Gunchilgyebok-Jung. J Kor Trad Oncol. 2015;20(1):23-29. https://doi.org/10.15432/JKTO.2015.20.1.023
  9. Zheng HM, Yoon JW, Lee YW, Cho CK, Ph DS, Yoo HS. Case Series of advanced non-small cell lung cancer patients treated with Hang-am Plus. J Int Korean Med. 2011;32(1):113-120.
  10. Park SJ, Kim SY, Cho CK, Jung IC, Yoo HS. Preliminary study to develop the instrument of oriental medical evaluation for lung cancer. J Korean Med. 2015;36(3):53-64. https://doi.org/10.13048/jkm.15019
  11. Park JG, Bang YJ, Ha SH. Oncology. 2nd rev. ed. Seoul:Iljogak. 2012:224-239.
  12. NCCN clinical practice guidelines in oncology (ver.8). National Comprehensive cancer network. 2020.
  13. Costa GJ, Ferreira CG, Thuler CS. Concurrent chemoradiotherapy for stage III non-small cell lung cancer: corredt clinical management as the basis to move beyond, Ann Transl Med. 2018;6(Suppl 1):S65. https://doi.org/10.21037/atm.2018.10.38
  14. Lee JC, Yun HY, Yoo HS, Bang SH. A case report of complete response of advanced gastric carcinoma patient treated with Korean medicine treatment in conjuction with chemoradiation therapy. J Kor Trad Oncol. 2014;19(1):25-32. https://doi.org/10.15432/JKTO.2014.19.1.25
  15. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487-497. https://doi.org/10.1016/S1470-2045(02)00818-5
  16. Garaci E, Pica F, Matteucci C, Gaziano R, D'Agostini C, Miele MT, et al. Historical review on thymosin α1 in oncology: preclinical and clinical experiences. Expert Opin Biol Ther. 2015;15(Suppl 1):S31-9.
  17. Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, et al, Intravenous Vitamin C and Cancer: A Systematic Review. Integr Cancer Ther. 2014 Jul;13(4):280-300. https://doi.org/10.1177/1534735414534463
  18. Kwon KR, Kim HD, Kim JS, Yoo HS, Cho CK. Case series of Non-small cell Lung cancer treated with mountain Ginseng pharmacopuncture. J Acupunct Meridian Stud. 2011;4(11):61-68. https://doi.org/10.1016/S2005-2901(11)60008-3
  19. Dai D, Zhang CF, Williams S, Yuan CS, Wang CZ. Ginseng on Cancer: Potential Role in Modulating Inflammation-Mediated Angiogenesis. Am J Chin Med. 2017;45(1): 13-22. https://doi.org/10.1142/s0192415x17500021